Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Moodys
Merck
Colorcon
McKinsey

Last Updated: February 3, 2023

CLINICAL TRIALS PROFILE FOR NICOTROL


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Nicotrol

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000437 ↗ Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) Completed National Institute on Alcohol Abuse and Alcoholism (NIAAA) Phase 4 1997-09-26 The purpose of this study is to determine the effectiveness of naltrexone (Revia) or matched placebo combined with nicotine patch (Nicotrol) or placebo patch using a 2x2 design in reducing drinking and smoking in patients with both nicotine and alcohol dependence.
NCT00000437 ↗ Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) Completed The Scripps Research Institute Phase 4 1997-09-26 The purpose of this study is to determine the effectiveness of naltrexone (Revia) or matched placebo combined with nicotine patch (Nicotrol) or placebo patch using a 2x2 design in reducing drinking and smoking in patients with both nicotine and alcohol dependence.
NCT00061074 ↗ Tobacco Cessation in Postmenopausal Women (Part II) - 2 Completed National Institute on Drug Abuse (NIDA) Phase 1 1993-03-01 The purpose of this study is to evaluate the effects of ERT on appetitive behavior and withdrawal in short-term smoking cessation in postmenopausal females on transdermal nicotine replacement
NCT00061074 ↗ Tobacco Cessation in Postmenopausal Women (Part II) - 2 Completed University of Minnesota Phase 1 1993-03-01 The purpose of this study is to evaluate the effects of ERT on appetitive behavior and withdrawal in short-term smoking cessation in postmenopausal females on transdermal nicotine replacement
NCT00061074 ↗ Tobacco Cessation in Postmenopausal Women (Part II) - 2 Completed University of Minnesota - Clinical and Translational Science Institute Phase 1 1993-03-01 The purpose of this study is to evaluate the effects of ERT on appetitive behavior and withdrawal in short-term smoking cessation in postmenopausal females on transdermal nicotine replacement
NCT00091468 ↗ Nicotine Treatment of Mild Cognitive Impairment (MCI) Unknown status National Institute on Aging (NIA) Phase 1 2003-09-01 The purpose of this 12-month study is to determine whether nicotine, administered in the form of nicotine patches, can improve symptoms of memory loss in some people experiencing mild memory problems (referred to in this study as "mild cognitive impairment" or MCI).
NCT00108342 ↗ Nicotine Delivery Systems: Research & Treatment Terminated US Department of Veterans Affairs N/A 2007-10-01 The purpose of this study is to determine whether sampling nicotine replacement treatments (NRTs) is superior to learning about them by computer. Testing also covers preferences among the treatments. Subjects will be enrolled veterans who smoke. Hypothesis: Direct experience ("sampling") of NRTs will increase knowledge about NRTs, motivation/confidence, use of NRTs and quit attempts in contrast to learning about NRTs by computer.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Nicotrol

Condition Name

Condition Name for Nicotrol
Intervention Trials
Smoking 3
Smoking Cessation 2
Alcoholism 1
Depressive Disorder 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Nicotrol
Intervention Trials
Tobacco Use Disorder 3
Depressive Disorder 2
Substance-Related Disorders 1
Alcoholism 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Nicotrol

Trials by Country

Trials by Country for Nicotrol
Location Trials
United States 13
Mexico 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Nicotrol
Location Trials
Tennessee 2
Pennsylvania 2
North Carolina 1
District of Columbia 1
Minnesota 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Nicotrol

Clinical Trial Phase

Clinical Trial Phase for Nicotrol
Clinical Trial Phase Trials
Phase 4 5
Phase 2 2
Phase 1 3
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Nicotrol
Clinical Trial Phase Trials
Completed 10
Terminated 1
Unknown status 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Nicotrol

Sponsor Name

Sponsor Name for Nicotrol
Sponsor Trials
National Institute on Drug Abuse (NIDA) 4
Vanderbilt University Medical Center 2
University of Pennsylvania 2
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Nicotrol
Sponsor Trials
Other 14
NIH 8
U.S. Fed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Mallinckrodt
Boehringer Ingelheim
McKesson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.